Repeat Radiosurgery for Sporadic Vestibular Schwannoma After Primary Radiosurgical Failure: An International Multi-institutional Investigation

Author:

Khandalavala Karl R.1,Herberg Hans A.2,Kay-Rivest Emily3,Moore Lindsay S.4,Yancey Kristen L.5,Marinelli John P.,Lund-Johansen Morten2,Kosaraju Nikitha4,Lohse Christine M.6,Kutz Walter5,Santa Maria Peter L.4,Golfinos John G.7,Kondziolka Douglas7,Carlson Matthew L.,Tveiten Øystein V.2,Link Michael J.

Affiliation:

1. Department of Otolaryngology–Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, U.S.A.

2. Department of Neurologic Surgery, Bergen University Hospital, Bergen, Norway

3. Department of Otolaryngology–Head and Neck Surgery, NYU Langone Health, New York, New York, U.S.A.

4. Department of Otolaryngology–Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, U.S.A.

5. Department of Otolaryngology–Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, U.S.A.

6. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, U.S.A.

7. Department of Neurologic Surgery, NYU Langone Health, New York, New York, U.S.A.

Abstract

Objective To describe outcomes of patients with sporadic vestibular schwannoma (VS) who underwent repeat stereotactic radiosurgery (SRS) after primary SRS failure. Study Design Multi-institutional historical cohort study. Setting Five tertiary care referral centers. Patients Adults ≥18 years old with sporadic VS. Intervention Primary and repeat treatment with SRS. Main Outcome Measure Microsurgery-free survival after repeat SRS. Results Across institutions, 32 patients underwent repeat SRS after primary SRS. Most patients (74%) had tumors with cerebellopontine angle extension at primary SRS (median size, 13.5 mm [interquartile range, 7.5–18.8] mm). After primary SRS, patients underwent repeat SRS at a median of 4.8 years (interquartile range, 3.2–5.7 yr). For treatment modality, 30 (94%) patients received gamma knife for primary treatment and 31 (97%) patients received gamma knife as their repeat treatment. Median tumor volume increased from 0.970 cm3 at primary SRS to 2.200 cm3 at repeat SRS. Facial nerve function worsened in two patients after primary SRS and in two patients after repeat SRS. There were no instances of intracranial complications after repeat SRS. Microsurgery-free survival rates (95% confidence interval; number still at risk) at 1, 3, and 5 years after repeat SRS were 97% (90–100%, 24), 84% (71–100%, 13), and 68% (48–96%, 6), respectively. There was one occurrence of malignancy diagnosed after repeat radiosurgery. Conclusion Overall, repeat SRS for sporadic VS has comparable risk profile, but lower rates of tumor control, compared with primary SRS.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference42 articles.

1. The stereotaxic method and radiosurgery of the brain;Acta Chir Scand,1951

2. A journey through 100 years of vestibular schwannoma surgery at Mayo Clinic: A historical illustrative case series;Otol Neurotol,2020

3. Vestibular schwannomas;N Engl J Med,2021

4. The changing landscape of vestibular schwannoma management in the United States—A shift toward conservatism;Otolaryngol Head Neck Surg,2015

5. Long-term outcomes after gamma knife surgery for vestibular schwannomas: A 10-year experience;J Neurosurg,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3